Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies

Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/41535

Título :	Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies
Autor:	Li, Ying Liu, Shanglong Zhang, Shuchao Ju, Qiang Zhang, Shaoqiang Yang, Yuanming Wang, Haiyan
Palavras-chave:	COVID-19 Convalescent plasma Plasmapheresis Mesenchymal stem cell
Publicador:	Elsevier
Data da publicação:	2020
Referência:	LI, Y. et al. Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies. Transfusion and Apheresis Science, [S.l.], 2020. No prelo.
Abstract:	COVID-19 is caused by SARS-CoV-2 which is a new enveloped virus that belongs to the Beta coronavirus genus. As a major health crisis, SARS-CoV-2 has infected over a million people around the world. There is currently no specific treatment available for patients with COVID-19 infection. Numerous potential therapies, including supportive intervention, immunomodulatory agents, antiviral therapy, and convalescent plasma transfusion, have been used in clinical practice. Herein, we summarize the current potential therapeutic approaches for diseases related to COVID-19 infection and discusses the clinical value of blood transfusion-related technologies used in COVID-19 treatment.
URI:	http://www.sciencedirect.com/science/article/pii/S1473050220301427 http://repositorio.ufla.br/jspui/handle/1/41535
Idioma:	en_US
Aparece nas coleções:	FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Arquivos associados a este item:

Não existem arquivos associados a este item.